Statistics

Total Visits

Views
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial42

File Visits

Downloads
36218-371.pdf22

Select a period of time:

Number of views in the range

Views
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial21

Number of downloads in the range

Downloads
36218-371.pdf10

Views

Views
October 20240
November 20240
December 20240
January 20250
February 20253
March 202518
April 20250
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • October 2024
    0
  • November 2024
    0
  • December 2024
    10
  • January 2025
    0
  • February 2025
    0
  • March 2025
    0
  • April 2025
    0
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore18
United States3
 

Top countries by downloads

Downloads
United States4
 

Top cities views

Views